Opioids - STAT

Health By Usha Lee McFarling

As the pandemic ushered in isolation and financial hardship, overdose deaths reached new heights

Pharmalot By Ed Silverman

McKinsey agrees to $573 million settlement over advice given Purdue and other opioid makers

Pharmalot By Ed Silverman

Advocacy groups urge Biden administration not to tap Woodcock as FDA commissioner

Pharmalot By Ed Silverman

‘Use that money wisely’: Coalition urges governments to spend opioid settlement funds on evidence-based efforts

Pharmalot By Ed Silverman

Sacklers withdrew cash from Purdue after opioid lawsuit fears were raised, documents show

Pharmalot By Ed Silverman

Sackler family members deny responsibility for the opioid crisis in a rare public appearance

Opioid photo illustration opioid overdose

Pharmalot By Ed Silverman

Opioid prescribing has dropped dramatically since 2011, but experts say there’s ‘more to go’

Pharmalot By Ed Silverman

Sackler family members agree to testify at House hearing on Purdue’s role in opioid crisis

Politics By Lev Facher

Patrick Kennedy pitches himself for Biden ‘drug czar’

Pharmalot By Ed Silverman

A historian was cited to support making Purdue a public benefit company. He actually thinks it’s a bad idea

Health By Damian Garde

‘I just white-knuckle it’: Hemophilia patients pin their hopes on the revival of Vioxx to fill a void in pain relief

First Opinion By Vanila Singh

Misguided federal regulations are likely to cause more pain in people already living with it

Pharmalot By Ed Silverman

House committee wants Purdue CEO and Sackler family members to testify at opioid crisis hearing

Pharmalot By Ed Silverman

To maintain opioid sales, Purdue was advised to pay rebates to health insurers for each overdose

Pharmalot By Ed Silverman

Pharmalittle: AstraZeneca Covid-19 vaccine shows promise in elderly; surprise rule will require insurers to estimate out-of-pocket drug costs

Pharmalot By Ed Silverman

Pharmalittle: Pfizer Covid-19 vaccine shows 95% effectiveness; FDA vows to disclose scientific data for EUAs

Pharmalot By Ed Silverman

Lawmakers urge Justice Department to revise $8.3 billion settlement with Purdue

Pharmalot By Ed Silverman

Purdue law firm hires Justice Department lawyer who investigated the opioid maker

Pharmalot By Ed Silverman

Lawmakers release trove of Purdue documents detailing Sackler family’s involvement in opioid sales

Don't Miss By STAT staff

As STAT turns 5, a look back at science and medicine’s biggest headlines and controversies

Pharmalot By Ed Silverman

Purdue will plead guilty to federal charges, reaches $8.3 billion deal over opioid crisis

Pharmalot By Ed Silverman

Lawmakers ask Justice Department to consider criminal charges against Purdue execs and the Sacklers

Pharmalot By Ed Silverman

State treasurers urge Cardinal Health shareholders to reject CEO bonus over opioid crisis

First Opinion By Richard Bottner, Christopher Moriates, and Matthew Stefanko

Stigma is killing people with substance use disorders. Health care providers need to rid themselves of it

Pharmalot By Ed Silverman

Most Read

Why fentanyl is deadlier than heroin, in a single photo

Trump administration will let nearly all doctors prescribe addiction medicine buprenorphine

FDA to require strong warnings about combining pain pills with anxiety medication

FTC sues drug makers over allegedly illegal deal over an opioid painkiller

Pharmalittle: Biden getting more pharma donations than Trump; FDA safety plan not ‘well suited’ for opioids

Are people really falling ill from touching fentanyl? In most cases, scientists say no

The history of OxyContin, told through unsealed Purdue documents

Stop persecuting doctors for legitimately prescribing opioids for chronic pain

All Coverage

As the pandemic ushered in isolation and financial hardship, overdose deaths reached new heights

McKinsey agrees to $573 million settlement over advice given Purdue and other opioid makers

Advocacy groups urge Biden administration not to tap Woodcock as FDA commissioner

‘Use that money wisely’: Coalition urges governments to spend opioid settlement funds on evidence-based efforts

Sacklers withdrew cash from Purdue after opioid lawsuit fears were raised, documents show

Sackler family members deny responsibility for the opioid crisis in a rare public appearance

Opioid prescribing has dropped dramatically since 2011, but experts say there’s ‘more to go’

Sackler family members agree to testify at House hearing on Purdue’s role in opioid crisis

Patrick Kennedy pitches himself for Biden ‘drug czar’

A historian was cited to support making Purdue a public benefit company. He actually thinks it’s a bad idea

‘I just white-knuckle it’: Hemophilia patients pin their hopes on the revival of Vioxx to fill a void in pain relief

Misguided federal regulations are likely to cause more pain in people already living with it

House committee wants Purdue CEO and Sackler family members to testify at opioid crisis hearing

To maintain opioid sales, Purdue was advised to pay rebates to health insurers for each overdose

Pharmalittle: AstraZeneca Covid-19 vaccine shows promise in elderly; surprise rule will require insurers to estimate out-of-pocket drug costs

Pharmalittle: Pfizer Covid-19 vaccine shows 95% effectiveness; FDA vows to disclose scientific data for EUAs

Lawmakers urge Justice Department to revise $8.3 billion settlement with Purdue

Purdue law firm hires Justice Department lawyer who investigated the opioid maker

Lawmakers release trove of Purdue documents detailing Sackler family’s involvement in opioid sales

As STAT turns 5, a look back at science and medicine’s biggest headlines and controversies

Purdue will plead guilty to federal charges, reaches $8.3 billion deal over opioid crisis

Lawmakers ask Justice Department to consider criminal charges against Purdue execs and the Sacklers

State treasurers urge Cardinal Health shareholders to reject CEO bonus over opioid crisis

Stigma is killing people with substance use disorders. Health care providers need to rid themselves of it

For two decades, the FDA approval process for opioids had numerous shortcomings, study finds